InvestorsHub Logo

GemBerri

02/03/22 10:08 AM

#227 RE: DreyDreyDrey #222

"For Mr. Shkreli, 35 years old, the risk is worth it. He plans to emerge from jail richer than he entered.

His back-of-the-commissary-envelope calculation indicates that Phoenixus could be worth $3.7 billion by the time he is due to be freed in 2023, according to a person familiar with his thinking. His plan involves acquiring more rare drugs in various stages of development and plowing money into an ambitious research-and-development agenda. Both are guided by his long days reading pharmaceutical research."

https://www.wsj.com/articles/martin-shkreli-steers-his-company-from-prisonwith-contraband-cellphone-11551973574

Although Marty is banned from pharma for life, I don't think this will stop him from using subsidiaries to run pharma companies.